• 1. A convenient approach to β-heteroarylated (C–N bond) ketones from Cs2CO3 promoted reaction between propargyl alcohols and nitrogen-heterocycles
  M. Bhanuchandra,Malleswara Rao Kuram,Akhila K. Sahoo Org. Biomol. Chem. 2012 10 3538
• 2. A modular, low footprint and scalable flow platform for the expedient α-aminohydroxylation of enolizable ketones
  Victor-Emmanuel H. Kassin,Romain Morodo,Thomas Toupy,Isaline Jacquemin,Kristof Van Hecke,Rapha?l Robiette,Jean-Christophe M. Monbaliu Green Chem. 2021 23 2336
• 3. A chemoselective α-aminoxylation of aryl ketones: a cross dehydrogenative coupling reaction catalysed by Bu4NI
  Yogesh Siddaraju,Kandikere Ramaiah Prabhu Org. Biomol. Chem. 2015 13 11651
• 4. A triphenylphosphine mediated photo-rearrangement and methanol addition of aryl chalcones to 1-propanones
  Qiu Sun,Chang Jiang Yao,Burkhard K?nig Photochem. Photobiol. Sci. 2015 14 948
• 5. Synthesis of enantiopure glycidol derivatives via a one-pot two-step enzymatic cascade
  Yu-Chang Liu,Yan Liu,Zhong-Liu Wu Org. Biomol. Chem. 2015 13 2146

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Aryl alkyl ketones

Recent Advances in the Study of 1-(2-Thienyl)-1-propanone (CAS: 13679-75-9) and Its Applications in Chemical Biology and Pharmaceutical Research

1-(2-Thienyl)-1-propanone (CAS: 13679-75-9) is a thiophene-based ketone compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including potential drug candidates. Recent studies have explored its role in the development of novel therapeutic agents, particularly in the fields of oncology, neurology, and infectious diseases. This research brief aims to provide an overview of the latest advancements related to 1-(2-Thienyl)-1-propanone, focusing on its synthesis, biological activities, and potential clinical applications.

One of the most notable developments in the study of 1-(2-Thienyl)-1-propanone is its application in the synthesis of heterocyclic compounds with promising pharmacological properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficient use of this compound as a building block for the development of thiophene-fused derivatives with potent anti-inflammatory and analgesic effects. The researchers employed a multi-step synthetic route, starting with 1-(2-Thienyl)-1-propanone, to generate a library of novel compounds. Subsequent in vitro and in vivo assays revealed that several derivatives exhibited significant COX-2 inhibitory activity, suggesting their potential as non-steroidal anti-inflammatory drugs (NSAIDs) with reduced gastrointestinal side effects.

In the field of oncology, 1-(2-Thienyl)-1-propanone has been investigated as a precursor for the synthesis of small-molecule inhibitors targeting specific cancer-related pathways. A recent study highlighted in Bioorganic & Medicinal Chemistry Letters reported the design and synthesis of a series of thiophene-based analogs derived from 1-(2-Thienyl)-1-propanone, which showed selective inhibition of protein kinases involved in tumor proliferation. Molecular docking studies further elucidated the binding interactions between these analogs and their target kinases, providing valuable insights for structure-activity relationship (SAR) optimization. These findings underscore the potential of 1-(2-Thienyl)-1-propanone as a scaffold for developing targeted cancer therapies.

Beyond its applications in drug discovery, 1-(2-Thienyl)-1-propanone has also been explored in the context of neurodegenerative diseases. A 2022 publication in European Journal of Medicinal Chemistry detailed the synthesis of novel neuroprotective agents using this compound as a starting material. The resulting derivatives demonstrated significant antioxidant and anti-apoptotic activities in neuronal cell models, offering potential therapeutic avenues for conditions such as Alzheimer's and Parkinson's diseases. These studies highlight the compound's versatility and its ability to serve as a foundation for diverse medicinal chemistry applications.

In conclusion, recent research on 1-(2-Thienyl)-1-propanone (CAS: 13679-75-9) has revealed its broad utility in chemical biology and pharmaceutical development. From its role as a synthetic intermediate to its potential as a scaffold for bioactive molecules, this compound continues to inspire innovative approaches in drug discovery. Future studies are expected to further explore its applications, particularly in optimizing drug-like properties and expanding its therapeutic potential. As the field advances, 1-(2-Thienyl)-1-propanone is poised to remain a valuable tool for researchers aiming to address unmet medical needs through rational drug design.

• 4565-29-1(5-Acetylthiophene-2-carbaldehyde)
• 7333-07-5(2,2'-thenil)
• 30711-41-2(2-Octanoylthiophene)
• 88-15-3(2-Acetylthiophene)
• 53119-25-8(1-(Thien-2-yl)pentan-1-one)
• 13679-74-8(2-Acetyl-5-methylthiophene)
• 97511-16-5(1-(2-Thienyl)-ethanone)
• 5333-83-5(1-Thien-2-ylbutan-1-one)
• 20409-48-7(2,2-dimethyl-1-(thiophen-2-yl)propan-1-one)
• 30711-40-1(2-(n-Heptanoyl)thiophene)